Skip to main content
梓橦宫 logo

梓橦宫 — Investor Relations & Filings

Ticker · 920566 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 625 across all filing types
Latest filing 2025-04-27 Board/Management Inform…
Country CN China
Listing Beijing Stock Exchange 920566

About 梓橦宫

http://www.zitonggong.com/

Zitonggong specializes in the research, development, and production of specialized therapeutic agents. Established with a heritage dating back to 1780, the company holds a recognized heritage brand designation. Its primary product portfolio centers on neurological and cerebrovascular health, featuring Oxiracetam in various dosage forms for treating cognitive dysfunction and brain injuries. The company also develops treatments for digestive health, including Compound Aloe Capsules, and produces artificial Oriental Bezoar. Operations are centered on integrating traditional medicinal knowledge with modern chemical synthesis and manufacturing standards. The company maintains a focus on clinical efficacy and technological advancement in the fields of neurology and gastroenterology.

Recent filings

Filing Released Lang Actions
2024年度独立董事述职报告（马毅）
Board/Management Information Classification · 95% confidence The document is titled '2024年度独立董事述职报告' which translates to '2024 Annual Independent Director's Work Report'. It is a detailed report by an independent director about their duties, attendance at board and committee meetings, communication with auditors, and engagement with shareholders during the year 2024. The content focuses on governance, oversight, and director activities rather than financial results or audit opinions. It is not an announcement of a report but the report itself. This fits best under Board/Management Information (MANG) as it relates to board member activities and governance reporting by a director. The document length is 2811 characters, which is consistent with a detailed director report rather than a brief announcement or certification. Therefore, the classification is MANG with high confidence.
2025-04-27 Chinese
会计政策变更公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a change in accounting policies by the company Sichuan Zitonggong Pharmaceutical Co., Ltd. It details the nature of the accounting policy changes, the reasons for the changes, and the approvals by the board, supervisory committee, and audit committee. The document does not contain full financial statements or comprehensive financial data but rather focuses on the policy change announcement and related approvals. It is not a full Annual Report (10-K), Interim Report (IR), or Audit Report (AR). Given the content and length (1389 characters), it is a regulatory announcement about accounting policy changes, which fits best under Regulatory Filings (RNS).
2025-04-27 Chinese
董事会关于独立董事独立性自查情况的专项报告
Board/Management Information Classification · 95% confidence The document is a special report from the board of directors regarding the independence of the company's independent directors. It references compliance with regulatory rules about independent directors and provides a detailed assessment of their independence. This type of document is a board/management information announcement related to governance and management oversight rather than a full annual report, audit report, or other financial filings. It is not a report publication announcement or a certification letter but a substantive report on board matters. Therefore, the appropriate classification is Board/Management Information (MANG).
2025-04-27 Chinese
2024年年度报告摘要
Annual Report Classification · 100% confidence The document is titled as an "年度报告摘要" which translates to "Annual Report Summary" and contains detailed financial data for the year 2024, including assets, liabilities, net profit, earnings per share, and shareholder information. It references the full annual report and encourages investors to read the full report on the Beijing Stock Exchange website. The document includes audit opinions, management assurances, and comprehensive financial and operational data typical of an annual report. The length is over 5,000 characters and contains substantive financial data, not just an announcement or certification. Therefore, this document is classified as an Annual Report (10-K). FY 2024
2025-04-27 Chinese
2024年年度报告
Annual Report Classification · 100% confidence The document is titled as the "2024 年年度报告" (2024 Annual Report) of 四川梓橦宫药业股份有限公司, which translates to Sichuan Zitonggong Pharmaceutical Co., Ltd. The text includes detailed sections typical of an annual report such as company overview, financial data and indicators, management discussion and analysis, major events, shareholder information, financing and profit distribution, board and senior management information, industry information, corporate governance, and financial accounting reports. It also contains audited financial data, management's discussion of business performance, risk factors, and detailed financial statements. The document length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. The presence of an auditor's unqualified opinion and detailed financial and operational data confirms this is the official comprehensive yearly report covering company activity and full financial performance. Therefore, the document is classified as an Annual Report (10-K). FY 2024
2025-04-27 Chinese
董事会财务与审计委员会对会计师事务所履行监督职责情况报告
Audit Report / Information Classification · 95% confidence The document is a report from the company's Board of Directors' Financial and Audit Committee regarding the supervision of the accounting firm's audit work for the fiscal year 2024. It details the audit firm's qualifications, the committee's oversight activities, and the conclusion that the audit was conducted properly and on time. The document does not contain the audit report itself or detailed financial statements but is a supervisory report on the audit process and the auditor's performance. This fits the definition of an Audit Report / Information (AR), which includes standalone audit reports and information about audit processes and results, excluding full annual reports. The document length is 1643 characters, which is consistent with a detailed report but not a full annual report. Therefore, the correct classification is AR with high confidence. FY 2024
2025-04-27 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.